What Are Non-Melanoma Skin Cancers and Where Do They Develop?
https://vimeo.com/953694743 What is non-melanoma skin cancer, and what are the different types? Dr. Soo Park defines this group of skin cancers and explains where they are typically found on the…
Elevate | What You Should Know About Your Role in AML Treatment and Care Decisions
https://vimeo.com/952046489How can you elevate your AML care and treatment? AML expert Dr. Gail Roboz discusses the importance of participating in AML treatment decisions, reviews key factors that may impact therapy…
Miguel’s Journey: Embracing CAR T-cell Therapy as a Latinx Myeloma Survivor
https://vimeo.com/951627946 Myeloma survivor Miguel wasn’t experiencing any symptoms when he received his shocking diagnosis. Watch as he shares his experience as a Latinx myeloma patient dealing with testing, multiple lines…
Advanced Non-Melanoma Skin Cancer Treatment | Partnering With Your Team on Care Decisions
https://vimeo.com/951261461 When making advanced non-melanoma skin cancer care and treatment decisions, what factors help determine the best approach for YOUR disease? Dr. Soo Park reviews current treatment options, emerging research,…
What Are Potential Impacts of Artificial Intelligence on AML Patient Care?
https://vimeo.com/948960199 How might acute myeloid leukemia (AML) patient care be impacted by artificial intelligence? Expert Dr. Andrew Hantel from Dana-Farber Cancer Institute and Harvard Medical School shares his perspective on potential risks…
What Is the Role of Bone Marrow Biopsies in AML Treatment?
https://vimeo.com/948960276 What part do bone marrow biopsies play in acute myeloid leukemia (AML) treatment? Expert Dr. Andrew Hantel from Dana-Farber Cancer Institute and Harvard Medical School discusses the value and information gained…
Why Is Shared Decision-Making Important for AML Patients?
https://vimeo.com/948960301 What makes shared decision-making vital for acute myeloid leukemia (AML) patients? Expert Dr. Andrew Hantel from Dana-Farber Cancer Institute and Harvard Medical School discusses his approach to shared decision-making, the roles…
Do AML Bone Marrow Biopsies Show Racial and Ethnic Variances?
https://vimeo.com/948960333 Are racial and ethnic differences shown in acute myeloid leukemia (AML) bone marrow biopsies? Expert Dr. Andrew Hantel from Dana-Farber Cancer Institute and Harvard Medical School discusses what early AML studies…
How Bone Marrow Biopsies Impact Acute Myeloid Leukemia Treatment and Care
https://vimeo.com/948960365 How are acute myeloid leukemia (AML) treatment and care impacted by bone marrow biopsies? Expert Dr. Andrew Hantel from Dana-Farber Cancer Institute and Harvard Medical School explains the role that bone…
Novel AML Therapy Use | Impact of Socioeconomic Status and Other Factors
https://vimeo.com/948960382 How do socioeconomic status and other factors impact novel acute myeloid leukemia (AML) therapy use? Expert Dr. Andrew Hantel from Dana-Farber Cancer Institute and Harvard Medical School discusses major factors that…
Underrepresented AML Clinical Trial Groups | What Solutions Are Underway?
https://vimeo.com/948960402 What steps are being taken to help underrepresented acute myeloid leukemia (AML) clinical trial groups? Expert Dr. Andrew Hantel from Dana-Farber Cancer Institute and Harvard Medical School discusses an important approach…
Why Is Post-Access Enrollment Vital in AML Clinical Trial Participation?
https://vimeo.com/948960428 For acute myeloid leukemia (AML) clinical trial participation, what makes post-access enrollment essential? Expert Dr. Andrew Hantel from Dana-Farber Cancer Institute and Harvard Medical School discusses factors that play into post-access…